| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $5,759,834 ) (Continued on the next page) |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 5 | NIH | 1/17/2024 | $20,000 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 000 | 5 | NIH | 11/15/2023 | $340,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 5 | NIH | 11/15/2023 | $363,714 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 001 | 5 | NIH | 12/6/2023 | $0 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 001 | 5 | NIH | 12/6/2023 | $0 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 5 | NIH | 11/15/2023 | $256,617 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 001 | 6 | NIH | 4/16/2024 | $493,946 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 4 | NIH | 10/31/2023 | $577,986 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 000 | 8 | NIH | 3/12/2024 | $432,620 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21HL173848 | Introducing NanoProTEN, a novel approach for anticoagulation in patients with prothrombotic autoantibodies | 000 | 1 | NIH | 3/29/2024 | $227,250 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15DC021563 | Speech Localization and Enhancement for Next-Generation Hearing Devices | 000 | 1 | NIH | 1/31/2024 | $451,688 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K22CA279495 | Elucidating Mechanisms of CAR ML NK cell biology to treat cancer and infection | 000 | 1 | NIH | 1/23/2024 | $186,030 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM152125 | Methods and technologies for chemical synthesis of glycans | 000 | 1 | NIH | 1/26/2024 | $439,023 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG087308 | Methods for treating aging-related cognitive decline and reducing risk of AD/ADRD by enhancing the endogenous expression of adropin | 000 | 1 | NIH | 4/12/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG083451 | An investigation of the response of preclinical mouse models of dementia to adropin therapy | 000 | 1 | NIH | 4/12/2024 | $416,625 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21NS137054 | Unraveling how neuropathic pain synaptic transcriptome is signaled by G-quadruplex folds | 000 | 1 | NIH | 3/11/2024 | $189,375 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AR081270 | Development of Injectable Super-Lubricious Microgels for Sustained Release of Platelet-Rich Plasma to Treat Post-Traumatic Osteoarthritis | 000 | 2 | NIH | 3/28/2024 | $516,254 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03AI178368 | Transcriptomic Quantitation of Hepatitis B Virus Surface Antigen from Integration | 000 | 2 | NIH | 3/18/2024 | $75,750 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R35GM149320 | Coordination of DNA Metabolism by Replication Protein A | 000 | 2 | NIH | 4/3/2024 | $491,951 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 2 | NIH | 12/13/2023 | $500,965 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 2 | NIH | 12/8/2023 | $531,461 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 2 | NIH | 12/7/2023 | $52,694 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 000 | 3 | NIH | 4/9/2024 | $286,335 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 000 | 3 | NIH | 2/27/2024 | $600,835 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23AR079035 | Neighborhood Barriers and Facilitators to Walking, the Epidemiology of Knee Osteoarthritis and Developing Effective Exercise Prescriptions | 000 | 3 | NIH | 1/25/2024 | $157,393 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DC019566 | Pharmacological Approaches for Transepithelial Delivery of Therapeutics to the Vocal Folds | 000 | 3 | NIH | 3/26/2024 | $602,131 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | K23DA053433 | A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women | 000 | 3 | NIH | 2/16/2024 | $177,480 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | T7635369 | Maternal and Child Health Public Health Training Program | 00 | 5 | HRSA | 4/15/2024 | $348,143 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS114289 | Role of oligomeric TDP-43 aggregate intermediates in ALS and frontotemporal dementia | 000 | 5 | NIH | 1/17/2024 | $320,875 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 000 | 5 | NIH | 1/10/2024 | $349,774 |
| | 2024 | 2024 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01EY031008 | Iron and Diabetic Retinopathy | 000 | 5 | NIH | 1/4/2024 | $378,750 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM133967 | Mechanisms of RPA, Recombinases, and Mediators in Homologous Recombination | 003 | 4 | NIH | 1/11/2024 | -$9,848 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 03 | 8 | HRSA | 11/3/2023 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 000 | 5 | NIH | 11/23/2023 | $74,048 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 08 | 1 | HRSA | 2/23/2024 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 07 | 1 | HRSA | 2/9/2024 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 06 | 1 | HRSA | 1/19/2024 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 05 | 1 | HRSA | 1/19/2024 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 1/8/2024 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/9/2023 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 12/1/2023 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG076812 | Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine. | 000 | 1 | NIH | 10/27/2023 | $0 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UG1HD113156 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | 000 | 1 | NIH | 1/24/2024 | -$50,000 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UG1HD113156 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | 000 | 1 | NIH | 1/24/2024 | -$66,667 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UG1HD113156 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | 000 | 1 | NIH | 1/24/2024 | -$1,106,471 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL168766 | Innovative Tools to Expand Music-Inspired Strategies for Blood Pressure and Stroke Prevention (I-TEST BP/Stroke) | 000 | 1 | NIH | 11/22/2023 | -$716,628 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS-HPV) | 000 | 2 | NIH | 4/17/2024 | -$517,440 |
| | 2024 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R25AI170379 | NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations | 000 | 2 | NIH | 3/13/2024 | -$337,345 |
|
